6.
Tieder J, Sullivan E, Stephans A, Hall M, DeLaroche A, Wilkins V
. Risk Factors and Outcomes After a Brief Resolved Unexplained Event: A Multicenter Study. Pediatrics. 2021; 148(1).
DOI: 10.1542/peds.2020-036095.
View
7.
Alouini S, Guinard J, Belin O, Mesnard L, Werner E, Prazuck T
. Maternal-Fetal Implications of SARS CoV-2 Infection during Pregnancy, Viral, Serological Analyses of Placenta and Cord Blood. Int J Environ Res Public Health. 2022; 19(4).
PMC: 8871763.
DOI: 10.3390/ijerph19042105.
View
8.
Alhomaizi A, Alhomaizi D, Willis S, Verdeli H
. Social Distancing in the Era of COVID-19: A Call for Maintaining Social Support for the Maternal Population. Glob Health Sci Pract. 2021; 9(2):229-237.
PMC: 8324190.
DOI: 10.9745/GHSP-D-20-00398.
View
9.
Alhaboob A
. Clinical Characteristics and Outcomes of Patients Admitted with Brief Resolved Unexplained Events to a Tertiary Care Pediatric Intensive Care Unit. Cureus. 2020; 12(6):e8664.
PMC: 7370642.
DOI: 10.7759/cureus.8664.
View
10.
Trevisanuto D, Cavallin F, Cavicchiolo M, Borellini M, Calgaro S, Baraldi E
. Coronavirus infection in neonates: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2020; 106(3):330-335.
DOI: 10.1136/archdischild-2020-319837.
View
11.
Smith E, Oakley E, Grandner G, Ferguson K, Farooq F, Afshar Y
. Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis. BMJ Glob Health. 2023; 8(1).
PMC: 9895919.
DOI: 10.1136/bmjgh-2022-009495.
View
12.
Ueda R, Nomura O, Maekawa T, Sakai H, Nakagawa S, Ishiguro A
. Independent risk factors for recurrence of apparent life-threatening events in infants. Eur J Pediatr. 2017; 176(4):443-448.
DOI: 10.1007/s00431-017-2855-6.
View
13.
Sankaran D, Nakra N, Cheema R, Blumberg D, Lakshminrusimha S
. Perinatal SARS-CoV-2 Infection and Neonatal COVID-19: A 2021 Update. Neoreviews. 2021; 22(5):e284-e295.
DOI: 10.1542/neo.22-5-e1001.
View
14.
Moore M, Stokes K, Hartert T
. The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses. Curr Opin Immunol. 2014; 25(6):761-8.
PMC: 4097120.
DOI: 10.1016/j.coi.2013.09.016.
View
15.
Simon A, Volz S, Hofling K, Kehl A, Tillman R, Muller A
. Acute life threatening event (ALTE) in an infant with human coronavirus HCoV-229E infection. Pediatr Pulmonol. 2007; 42(4):393-6.
PMC: 7167760.
DOI: 10.1002/ppul.20595.
View
16.
Al-Kindy H, Gelinas J, Hatzakis G, Cote A
. Risk factors for extreme events in infants hospitalized for apparent life-threatening events. J Pediatr. 2008; 154(3):332-7, 337.e1-2.
DOI: 10.1016/j.jpeds.2008.08.051.
View
17.
Principi N, Autore G, Ramundo G, Esposito S
. Epidemiology of Respiratory Infections during the COVID-19 Pandemic. Viruses. 2023; 15(5).
PMC: 10224029.
DOI: 10.3390/v15051160.
View
18.
Claudius I, Mittal M, Murray R, Condie T, Santillanes G
. Should infants presenting with an apparent life-threatening event undergo evaluation for serious bacterial infections and respiratory pathogens?. J Pediatr. 2014; 164(5):1231-1233.e1.
DOI: 10.1016/j.jpeds.2013.12.027.
View
19.
Maddali R, Cervellione K, Lew L
. Apnea in a Two-Week-Old Infant Infected with SARS-CoV-2 and Influenza B. Case Rep Pediatr. 2022; 2022:2969561.
PMC: 8941565.
DOI: 10.1155/2022/2969561.
View
20.
Piumelli R, Davanzo R, Nassi N, Salvatore S, Arzilli C, Peruzzi M
. Apparent Life-Threatening Events (ALTE): Italian guidelines. Ital J Pediatr. 2017; 43(1):111.
PMC: 5728046.
DOI: 10.1186/s13052-017-0429-x.
View